Scott A. Tomlins, M.D., Ph.D. obtained his M.D. and Ph.D. at the University of Michigan Medical School (UMMS). His thesis, completed under the mentorship of Arul Chinnaiyan, M.D., Ph.D., described the identification and characterization of recurrent ETS gene fusions in prostate cancer. He completed residency in Anatomic Pathology at the University of Michigan Health System in June 2012 and is an Assistant Professor of Pathology and Urology, and a member of the Michigan Center for Translational Pathology (MCTP) at UMMS.
Dr. Tomlins is an active member of the diagnostic Genitourinary Pathology service and has co-authored over 100 manuscripts, focusing on the integrative analysis, functional characterization and clinical translation of cancer genomics, particularly focused on genitourinary malignancies. In addition, he led the development and signs out the urine-based prostate cancer early detection test (MiPS) offered through the MCTP’s clinical lab. He led the first exome sequencing based study of castration resistant prostate cancer and is developing broadly applicable personalized medicine approaches to prostate cancer early detection, prognosis and treatment of advanced disease.
In 2013, in recognition of his work in the molecular pathology of prostate cancer, he was awarded the inaugural AAAS Martin and Rose Wachtel Cancer Research Award for Young Investigators.